A novel agonist of PPAR- based on barbituric acid alleviates the development of non-alcoholic fatty liver disease by regulating adipocytokine expression and preventing insulin resistance
The ChaC family (ChaC1 and ChaC2, cytoplasmic glutathione-specific -glutamyl cyclotransferases) has recently been shown to take part in GSH metabolism
For a full list and details see MMC is currently an employee of Gameto Inc., which is developing cell-based therapies for reproductive medicine
Q-XT: Writingoriginal draft, Conceptualization, Data curation, Formal Analysis, Investigation, Methodology, Visualization, Writingreview and editing
So both for the cardiovascular effect, but also for the kidney effect, it is likely mostly an effect of reducing the severity of diabetes and treating diabetes and help managing diabetes, but also reducing the weight, which both seems to be contributing to the cardiovascular risk, progression of kidney disease, but there is some evidence that it may also be a direct effect of these drugs on the vasculature, so the vessels, potentially also on the kidneys and the heart